GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
Primary Open-Angle Glaucoma
Interventions
DEVICE

GlaucoT Glaucoma Treatment Device

"In this study, flicker light therapy, the effectiveness of which was investigated in the treatment of glaucoma based on some methods used in different diseases, is described for the first time in glaucoma.~Studies investigating the neurodegenerative properties of glaucoma have found similarities in the pathophysiology of Alzheimer's disease and glaucoma.~40 Hz flicker of light Alzheimer 's the positive effects on the knitted cortex have also been shown in studies. 40 Hz flicker light is aimed to reduce glaucoma and retinal ganglion cell loss due to glaucoma, by reducing neurodegeneration by decreasing amyloid and metabolite accumulation by increasing both microglial phagocytic activation effect and retinal blood flow."

Trial Locations (2)

35100

Ege University Department of Ophthalmology, Izmir

45030

Manisa Celal Bayar University Department of Ophthalmology, Manisa

All Listed Sponsors
lead

Glaucot Teknoloji Anonim Sirketi

INDUSTRY